Clin2
NCT07455955Possibly a fitRecruiting

Custom anti-nausea treatment based on your genes

Breast Cancer

Part of Cancer, Skin clinical trials.

This trial tests if giving anti-nausea drugs based on your genetic makeup can better prevent vomiting and nausea from chemotherapy for early breast cancer. You will receive a personalized regimen tailored to your pharmacogenetic profile.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
200 people
Ages
18 years to 74 years
Study type
Interventional

Who can take part

  • You are a Chinese woman between 18 and 74 years old.
  • You have early breast cancer (not advanced) and have not had chemotherapy before.
  • You are about to receive your first treatment with specific chemotherapy drugs (AC or FEC).
  • You are not pregnant and agree to use birth control if premenopausal.
  • You can read and fill out questionnaires and diaries.
  • You do not have conditions like glaucoma, seizures, or Parkinson's disease.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05841849Not yet recruiting· Phase 4
IV vs oral anti-nausea drugs to prevent chemo nausea

This Phase 4 study tests whether taking anti-nausea medicines through a vein (IV) or by mouth (oral) works better when combined to prevent nausea from breast cancer chemotherapy. It also checks safety, meaning side effects and how well people tolerate the medicines.

Hanzhou, Zhejiang
NCT07743827Recruiting
Olanzapine-based steroid-sparing anti-nausea treatment for breast cancer

This trial tests a new anti-nausea medicine combination for breast cancer patients getting AC chemotherapy, specifically designed for those with diabetes, obesity, or other metabolic issues. It aims to reduce the need for steroids, which can be riskier for these patients.

Alexandria, Alexandria Governorate
NCT07761325Not yet recruiting· Phase 3
Aromatherapy added to standard anti-nausea care for breast cancer patients

This study looks at whether adding aromatherapy to standard anti-nausea medication helps prevent nausea and vomiting caused by strong chemotherapy in breast cancer patients. If it works, aromatherapy could be an easy, drug-free way to feel better during treatment.

NCT06200168Recruiting· Phase 3
Electroacupuncture to prevent nausea during breast cancer chemo

This study tests whether electroacupuncture can help prevent nausea and vomiting caused by strong chemotherapy in people with breast cancer. If you're starting a certain type of chemo, this could help you feel better during treatment.

Xining, Qinghai
NCT06314906Recruiting· Phase 3
Acupuncture plus anti-nausea drugs for breast cancer chemo side effects

This trial tests whether adding electroacupuncture (a type of acupuncture with mild electrical pulses) to standard anti-nausea medicine can better prevent nausea and vomiting caused by strong chemotherapy. It is for people with early-stage breast cancer who are about to start a very strong chemotherapy regimen.

Lanzhou, Gansu
NCT07169851Recruiting· Phase 2
Study of a new drug for chemo nausea and vomiting

This trial tests a medication called LY3537021 to see if it can prevent nausea and vomiting caused by certain types of chemotherapy (AC or cisplatin) in people who have not had chemo before. It focuses on patients who are otherwise in fairly good health.

Greenbrae, California

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.